| Journal | Issue | Title | Abstract | File |
| REMEDIUM | No 4-6 (2020) | Overview of key launches on the Russian pharmaceutical market, 2019 | Abstract |
 (Rus) |
| Kalinina N. | ||||
| REMEDIUM | No 7-8 (2018) | Overview of the German pharmacy market | Abstract |
(Rus) |
| Trofimova E.O., Kareva N.N. | ||||
| REMEDIUM | No 9 (2018) | Overview of the medical market: current state and prospects of development of the Russian blood-collection devices market | Abstract |
(Rus) |
| Vanin A. | ||||
| REMEDIUM | No 3 (2021) | Overview of the Russian market of herbal products | Abstract |
(Rus) |
| Safonova N.V., Trofimova E.O. | ||||
| REMEDIUM | No 1-3 (2020) | Pain kept at bay by skilled practitioners | Abstract |
(Rus) |
| Shirokova I., Prozherina J. | ||||
| REMEDIUM | No 9 (2018) | Patent Linkage in foreign legal systems: balance of counterweights | Abstract |
(Rus) |
| Borzova M. | ||||
| REMEDIUM | No 2 (2022) | Peoples preferential provision of medicines, medical devices, specialized health food products: system and regulation in the Perm region | Abstract |
(Rus) |
| Maleeva T.L., Shilnikova S.V., Novikova N.V., Tarasevich V.N. | ||||
| REMEDIUM | No 9 (2018) | Peptides against stroke | Abstract |
(Rus) |
| Shirokova I., Prozherina J. | ||||
| REMEDIUM | No 1-2 (2019) | Personality traits affecting the communication between pharmacists and consumers | Abstract |
(Rus) |
| Zheltkevich O.V., Sibireva A.D. | ||||
| REMEDIUM | No 11 (2018) | Pertussis: do not play with infection! | Abstract |
(Rus) |
| Kaplya-Bubenets V. | ||||
| REMEDIUM | No 1-2 (2018) | Pharma industry enterprises investment prospects rating for 2016 | Abstract |
(Rus) |
| Romanova S. | ||||
| REMEDIUM | No 3 (2018) | Pharma industry enterprises investment prospects rating for 2016 | Abstract |
(Rus) |
| Romanova S. | ||||
| REMEDIUM | No 13S (2018) | Pharmaceutical advertising at-year end 2017 | Abstract |
(Rus) |
| Article E. | ||||
| REMEDIUM | No 11 (2019) | Pharmaceutical advice: efficacy and safety | Abstract |
(Rus) |
| Petrova S.V., Kononova S.V., Ponomareva A.A., Zhukova O.V., Shalenkova E.V., Chesnokova N.N., Bogomolova L.S., Dadus N.N. | ||||
| REMEDIUM | No 2 (2021) | Pharmaceutical industry for 2020 | Abstract |
(Rus) |
| Romanova S. | ||||
| REMEDIUM | No 6 (2018) | Pharmaceutical industry for Q I, 2018 | Abstract |
(Rus) |
| Romanova S. | ||||
| REMEDIUM | No 10 (2020) | Pharmaceutical industry in the first half of 2020 | Abstract |
(Rus) |
| Romanova S. | ||||
| REMEDIUM | No 2 (2021) | Pharmaceutical manufacturers ranking by gross profit in 2020 | Abstract |
(Rus) |
| Romanova S. | ||||
| REMEDIUM | No 3 (2021) | Pharmaceutical manufacturers ranking by sales profit for 2020 | Abstract |
(Rus) |
| Romanova S. | ||||
| REMEDIUM | No 1-2 (2018) | Pharmaceutical retail visitor traffic intensity analysis using big data technology elements | Abstract |
(Rus) |
| Umarov S.Z., Narkevich K.I. | ||||
| REMEDIUM | No 4 (2021) | Pharmacies of Smolensk province (XVIII-early XX century) | Abstract | |
| Konopleva E.L., Konoplev O.A. | ||||
| REMEDIUM | No 5 (2019) | Pharmacoeconomic analysis of ALK inhibitors in treatment of advanced or metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer | Abstract |
(Rus) |
| Belousov D.Y., Cheberda A.E., Afanasieva E.V., Zhuravleva M.V., Sakaeva D.D. | ||||
| REMEDIUM | No 1-2 (2018) | Pharmacoeconomic analysis of fulvestrant use in the first line therapy of metastatic breast cancer | Abstract |
(Rus) |
| Krysanov I.S., Konstantinova M.M., Ermakova V.Y., Vaskova L.B., Tyapkina M.V. | ||||
| REMEDIUM | No 2 (2022) | Pharmacoeconomical analysis of treatment regimens for diabetes mellitus in outpatient settings | Abstract |
(Rus) |
| Krylova O.V., Litvinova T.M., Denisova M.N., Markova T.M. | ||||
| REMEDIUM | No 3 (2022) | Pharmacokinetics and safety of the generic Praziquantel during its bioequivalence study | Abstract |
(Rus) |
| Gildeeva G.N., Chaplenko A.A., Stepanova E.S. | ||||
| 351 - 375 of 612 Items | << < 10 11 12 13 14 15 16 17 18 19 > >> | |||